2-61008836-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144709.4(PUS10):c.306G>T(p.Lys102Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,609,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144709.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUS10 | NM_144709.4 | c.306G>T | p.Lys102Asn | missense_variant | 3/18 | ENST00000316752.11 | NP_653310.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUS10 | ENST00000316752.11 | c.306G>T | p.Lys102Asn | missense_variant | 3/18 | 1 | NM_144709.4 | ENSP00000326003 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 250156Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135178
GnomAD4 exome AF: 0.000241 AC: 351AN: 1457184Hom.: 0 Cov.: 30 AF XY: 0.000219 AC XY: 159AN XY: 725024
GnomAD4 genome AF: 0.000125 AC: 19AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.306G>T (p.K102N) alteration is located in exon 3 (coding exon 2) of the PUS10 gene. This alteration results from a G to T substitution at nucleotide position 306, causing the lysine (K) at amino acid position 102 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at